KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Treasury Shares: 2019-2025

Historic Treasury Shares for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Sep 2025 value amounting to $4.7 million.

  • Ginkgo Bioworks Holdings' Treasury Shares rose 14.12% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 14.12%. This contributed to the annual value of $3.3 million for FY2024, which is 12.55% down from last year.
  • Ginkgo Bioworks Holdings' Treasury Shares amounted to $4.7 million in Q3 2025, which was down 6.01% from $5.0 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Treasury Shares' 5-year high stood at $238.7 million during Q1 2024, with a 5-year trough of -$2.7 million in Q3 2021.
  • In the last 3 years, Ginkgo Bioworks Holdings' Treasury Shares had a median value of $5.0 million in 2025 and averaged $93.9 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 8,066.28% in 2022, then crashed by 98.28% in 2025.
  • Ginkgo Bioworks Holdings' Treasury Shares (Quarterly) stood at $168.3 million in 2021, then decreased by 20.13% to $134.4 million in 2022, then tumbled by 97.17% to $3.8 million in 2023, then fell by 12.55% to $3.3 million in 2024, then increased by 14.12% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $5.0 million for Q2 2025, and $4.1 million during Q1 2025.